| [1] |
FENG Yuxi, WANG Jinjin, CAI Yi, ZHU Runzhi, ZHU Qin.
Research Progress on Protein Lactylation in Kidney Diseases
[J]. Chinese General Practice, 2026, 29(21): 3056-3063.
|
| [2] |
ZHANG Shiya, MIAO Tongguo, LOU Xianzhe, ZHANG Yunjing, MA Dong, NAN Yuemin.
Predictive Value of Serum HDL-C in the Occurrence of PVTT in Patients with NBNC-HCC
[J]. Chinese General Practice, 2026, 29(11): 1441-1447.
|
| [3] |
ZHOU Hongmei, HE Lin, XU Hui, WANG Ning.
A Systematic Review of Fatigue Assessment Tools for Cancer Patients Based on the COSMIN Guidelines
[J]. Chinese General Practice, 2026, 29(08): 965-973.
|
| [4] |
YANG Haifei, SUN Wu, WU Cheng, REN Wei, LI Rutian.
Analysis of Predictors for Immune-related Adverse Events and the Correlation with Efficacy in Progressive Esophageal Squamous Cell Carcinoma
[J]. Chinese General Practice, 2026, 29(06): 710-717.
|
| [5] |
ZHANG Shujing, SUN Lixin, CAO Yuqing.
Comparative Study on the Clinicopathological Features and Prognostic between HPV-related and Non-HPV-related Cervical Adenocarcinoma
[J]. Chinese General Practice, 2025, 28(14): 1758-1764.
|
| [6] |
YUAN Xiaorui, TAN Yanlin, FU Chun.
Construction of the Predictive Model for Lymph Node Metastasis in Patients with Epithelial Ovarian Cancer: Based on 18F-FDG PET/CT Radiomics Technology
[J]. Chinese General Practice, 2025, 28(12): 1465-1472.
|
| [7] |
ZHANG Yushuang, WU Zhongbing, HUANG Ming, JIA Lei, GAO Shuang, ZHAO Weipeng, LI Jing.
Study on Metabolic Characteristics in Esophageal Squamous Cell Carcinoma Patients with TCM Differentiation of Deficiency of Fluid and Blood Based on Non Target Metabolomics
[J]. Chinese General Practice, 2025, 28(12): 1513-1519.
|
| [8] |
LOU Xianzhe, MIAO Tongguo, ZHANG Shiya, MA Dong, NAN Yuemin.
The Impact of the Monocyte-to-High-Density Lipoprotein Cholesterol Ratio on the Prognosis of Patients with Non-Viral, Non-Alcoholic Hepatocellular Carcinoma: a Retrospective Cohort Study
[J]. Chinese General Practice, 2025, 28(09): 1092-1099.
|
| [9] |
MA Xiaoxuan, WANG Rongqi.
Research Progress in Metabolomics for HCC Diagnosis and Treatment
[J]. Chinese General Practice, 2025, 28(08): 1017-1022.
|
| [10] |
SONG Fenfen, LI Shengmian.
Real-World Study of Camrelizumab-based Regimen for Locally Advanced and Metastatic Esophageal Cancer
[J]. Chinese General Practice, 2025, 28(07): 844-852.
|
| [11] |
ZHANG Jin, SUN Di, WANG Hao, SHI Cong, ZHAO Yihan, PAN Yijin, MU Zhuanzhuan, DING Zhiguo, LIN Yansong.
Factors Influencing Biochemical Progression in Distant Metastatic Papillary Thyroid Carcinoma
[J]. Chinese General Practice, 2024, 27(36): 4546-4553.
|
| [12] |
YANG Anyin, LIU Hongli, CHEN Miaoyang, ZHENG Yufeng, XU Zhiyuan, YANG Yongfeng.
Mechanism and in Vitro Experiment of Wogonin in Treatment of Hepatocellular Carcinoma Based on Network Pharmacology
[J]. Chinese General Practice, 2024, 27(32): 4040-4049.
|
| [13] |
CHEN Chao, CHEN Tianxiang, LIU Qianwei, ZHANG Zhi, WANG Huanhuan, WU Pingping, GAO Lei, YU Zhaoxiang.
Analysis and Identification of Hub Genes in Hepatocellular Carcinoma Based on Weighted Gene Co-expression Network and Cancer Genome Atlas Clinical Data
[J]. Chinese General Practice, 2024, 27(32): 4050-4059.
|
| [14] |
MAIERHABA· Maimaitiaili, ZHANG Kainan, ZHAO Hui, YAKUFU· Tuoheti, YE Jianwei, LYU Guodong.
Investigating Serum PARP2 as a Potential Diagnostic Biomarker for Hepatocellular Carcinoma
[J]. Chinese General Practice, 2024, 27(32): 4060-4065.
|
| [15] |
HU Lingxi, LI Mei, FU Yiwei, LU Lixia, MA Xiaoxuan, WANG Rongqi, NAN Yuemin.
The Value of Serum VEGF in Evaluating the Clinical Efficacy of TACE Alone or Combined with Target Immunotherapy in Advanced Hepatocellular Carcinoma
[J]. Chinese General Practice, 2024, 27(32): 4033-4039.
|